3-BROMO-6-CHLORO-1H-PYRAZOLO[4,3-C]PYRIDINE, 95%, 250mg

1,4-Difluorobenzene, 99.0%, 1kg

Récipient de réaction à bride plate cylindrique, gradué (1) Fond rond, DN 150, 160 mm, Hauteur, 335 mm, 1 Pièce

Methyl (3S,4S)-4-((tert-butoxycarbonyl)amino)piperidine-3-carboxylate, 97%, 100mg

(1-(Tert-butoxycarbonyl)-1H-pyrrol-3-yl)boronic acid, 98%, 250mg

2-Cyclopentylthiazole-5-carboxylic acid, 97%, 5g

1,3,2-Dioxaborolane, 2-[3-[(2,4-dichlorophenyl)methoxy]phenyl]-4,4,5,5-tetramethyl-, 95%, 5g

(4-Hydroxy-thiazol-2-yl)acetic acid ethyl ester, 5g

4-(2-(1H-IMIDAZOL-1-YL)ETHOXY)BENZOIC ACID HYDROCHLORIDE, 95%, 50mg

2-(2,6-DIFLUOROPHENYL)-N-METHOXY-N-METHYLACETAMIDE, 95.0%, 1g

1-Fluorodecane, 98.0%, 1g

D-Mannono-1,4-lactone>97.0%(GC)1g

4-((5-Bromopyridin-3-yl)sulfonyl)morpholine, 95.0%, 250mg